Novartis Can't Dodge $2.2M Jaw Injury Verdict

Law360, New York (January 2, 2014, 8:24 PM EST) -- A California federal judge on Monday upheld a $2.2 million verdict against Novartis Pharmaceutical Corp. in a woman's lawsuit over a jaw injury allegedly caused by the bone drugs Aredia and Zometa, holding the drugmaker had a duty to warn of the risk of injury.

U.S. District Judge S. James Otero denied Novartis' motion for judgment as a matter of law as well as a new trial. Plaintiff Adriann Georges sufficiently showed that Novartis had a duty to warn her of the jaw injury risk and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Adriann Georges v. Novartis Pharmaceuticals Corporation et al


Case Number

2:06-cv-05207

Court

California Central

Nature of Suit

Personal Inj. Prod. Liability

Judge

S. James Otero

Date Filed

August 18, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.